NASDAQ:SWAV - Shockwave Medical Stock Price, Forecast & News

Shockwave Medical's stock was trading at $34.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SWAV stock has decreased by 20.9% and is now trading at $27.25. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Shockwave Medical.

Shockwave Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Shockwave Medical.

Shockwave Medical Inc (NASDAQ:SWAV) released its quarterly earnings results on Thursday, February, 13th. The company reported ($0.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.51) by $0.02. The company earned $14.31 million during the quarter, compared to analysts' expectations of $13.34 million. Shockwave Medical had a negative net margin of 119.06% and a negative return on equity of 37.20%. View Shockwave Medical's earnings history.

Shockwave Medical issued an update on its FY 2020 After-Hours earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $74-77 million, compared to the consensus revenue estimate of $75.34 million.

7 equities research analysts have issued 1 year price objectives for Shockwave Medical's stock. Their forecasts range from $23.00 to $54.00. On average, they anticipate Shockwave Medical's stock price to reach $44.43 in the next year. This suggests a possible upside of 63.0% from the stock's current price. View analysts' price targets for Shockwave Medical.

Headlines about SWAV stock have been trending very negative on Thursday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Shockwave Medical earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutShockwave Medical.

Shockwave Medical saw a increase in short interest in March. As of March 13th, there was short interest totaling 3,945,400 shares, an increase of 5.5% from the February 27th total of 3,740,000 shares. Based on an average trading volume of 560,600 shares, the short-interest ratio is currently 7.0 days. Approximately 20.2% of the company's stock are short sold. View Shockwave Medical's Current Options Chain.

Some companies that are related to Shockwave Medical include Globus Medical (GMED), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Integra Lifesciences (IART), Nevro (NVRO), NuVasive (NUVA), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Cantel Medical (CMD), Inspire Medical Systems (INSP), AtriCure (ATRC), Cardiovascular Systems (CSII), Glaukos (GKOS), Atrion (ATRI) and Luminex (LMNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Paypal (PYPL), Walt Disney (DIS), Twilio (TWLO), Roku (ROKU), Trade Desk (TTD), Veeva Systems (VEEV) and Home Depot (HD).

(SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SWAV stock can currently be purchased for approximately $27.25.

Shockwave Medical has a market capitalization of $865.62 million and generates $42.93 million in revenue each year. The company earns $-51,110,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. Shockwave Medical employs 162 workers across the globe. View additional information about Shockwave Medical.

The official website for Shockwave Medical is http://www.shockwavemedical.com/.

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]